7. COMMON SHARES (Details 1) |
6 Months Ended |
|---|---|
|
Dec. 31, 2020
$ / shares
shares
| |
| SHAREHOLDERS' EQUITY | |
| Number of warrants outstanding, beginning | shares | 0 |
| Number of warrants granted | shares | 1,100,000 |
| Number of warrants exercised | shares | 0 |
| Number of warrants expired | shares | 0 |
| Number of warrants outstanding, ending | shares | 1,100,000 |
| Weighted average exercise price outstanding, beginning | $ / shares | $ .00 |
| Weighted average exercise price granted | $ / shares | .25 |
| Weighted average exercise price exercised | $ / shares | .00 |
| Weighted average exercise price expired | $ / shares | .00 |
| Weighted average exercise price outstanding, ending | $ / shares | $ .25 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|